The proposed mechanisms for the sequence are shown in
Scheme 2. The first step involves the attack of the endocyclic
Synthesis of derivatives 4b-h:
nitrogen
atom
of
5-amino-3-arylamino-1H-pyrazole-4-
The reaction procedure was as described for 4a, but the
reaction time and conditions were as those reported in Table 1.
Only the intermediate 4a was isolated in pure form and its
structure was determined by FT-IR, H NMR, C NMR and
elemental analysis. The other intermediates were not isolated and
the subsequent reactions was carried out following evaporation of
the solvent and addition of EtOH to the residue.
carbonitrile 3a-f, which is more nucleophilic due to the electron-
withdrawing effect of the pyrazole ring, onto α-
bromoacetophenone 2a,b to form intermediates 4a-h. These are
converted into the desired products 5a-h through intramolecular
cyclocondensation of the amino and carbonyl groups.
1
13
General procedure for the synthesis of 2-aryl-6-
(arylamino)-1H-imidazo[1,2-b]pyrazole-7-carbonitiles 5a-h:
Synthesis of 2-phenyl-6-(phenylamino)-1H-imidazo[1,2-
b]pyrazole-7-carbonitrile (5a):
A
suspension
of
5-amino-1-(2-oxo-2-phenylethyl)-3-
(phenylamino)-1H-pyrazole-4-carbonitrile (4a) (317 mg,
1
mmol) in absolute EtOH (15 mL) and concentrated HCl (4 drops)
was refluxed for 1.5 h. The mixture was cooled to room
temperature and poured in cold H O (30 mL). The pH of solution
2
was adjusted to 7-8 by addition of dilute NaOH and the
precipitate was filtered and washed with cold H O (3×5 mL) and
2
dried to give the cyclocondensation product 5a as a white solid,
o
Mp. 265-266 (dec.) C.
Scheme 2. The proposed reaction mechanisms for the
formation of 4a-h and 5a-h.
-1
FT-IR (KBr) (νmax, cm ): 3235, 3201, 3161, 3072, 2204,
622, 1555, 1482, 1301, 692. H NMR (400 MHz, DMSO-d ) δ
ppm): 12.74 (1H, br s, NH, exchanged by D O addition), 8.88
1H, s, NH, exchanged by D O addition), 8.22 (1H, s, arom),
.74 (2H, d, J = 8 Hz, arom), 7.59 (2H, d, J = 8.4 Hz, arom), 7.46
2H, t, J = 7.6 Hz, arom), 7.34 (1H, t, J = 7.2 Hz, arom), 7.26
2H, t, J = 7.6 Hz, arom), 6.84 (1H, t, J = 7.2 Hz, arom).
NMR (100 MHz, DMSO-d ) δ (ppm): 156.32, 142.03, 140.70,
1
1
(
(
7
(
(
6
H
1
The structures of all products were confirmed from their H
2
1
3
NMR, C NMR and FT-IR spectral data and by elemental
analysis.
2
1
3
In summary, we have described a convenient and facile
synthesis of 2-aryl-6-(arylamino)-1H-imidazo[1,2-b]pyrazole-7-
carbonitriles by reaction of 5-amino-3-arylamino-1H-pyrazole-4-
carbonitriles with α-bromoacetophenones in the presence of
C
6
C
1
1
30.31, 129.12, 129.08, 128.69, 127.93, 124.24, 120.02, 116.82,
15.29, 106.32, 55.57. Anal. Calcd for C H N : C, 72.23; H,
4.38; N, 23.40. Found: C, 72.32; H, 4.21; N, 23.49.
1
8
13
5
K CO , followed by the cyclocondensation of the resulting 5-
2
3
amino-1-(2-oxo-2-arylethyl)-3-(arylamino)-1H-pyrazole-4-
carbonitrile intermediates. The salient features of this procedure
are mild reaction conditions, good yields, operational simplicity,
ready availability of the starting materials and applications
potential for the synthesis of other heterocyclic compounds.
Synthesis of 2-aryl-6-(arylamino)-1H-imidazo[1,2-b]pyrazole-
7
-carbonitiles 5b-h:
Absolute EtOH and concentrated HCl were added to the the
residue 4b-h and the mixture was refluxed for appropriate
amount of time (Table 2). The mixture was left to cold to room
General procedure for the synthesis of 5-amino-1-(2-oxo-2-
arylethyl)-3-(arylamino)-1H-pyrazole-4-carbonitriles 4a-h:
temperature. The resulting precipitate was washed with cold H O
2
(3×5 mL) and cold MeOH (5 mL) and dried to give the desired
products 5b-h.
5
-Amino-1-(2-oxo-2-phenylethyl)-3-(phenylamino)-1H-
pyrazole-4-carbonitrile (4a): A suspension of compound 3a (199
mg, 1 mmol), α-bromoacetophenone 2 (199 mg, 1 mmol) and
K CO (140 mg, 1 mmol) in dry acetone (15 mL) and DMF (3
Acknowledgments
2
3
The authors gratefully acknowledge the financial assistance
from Urmia University.
drops) was refluxed for 1 h. The mixture was cooled to room
temperature and poured into cold H O (30 mL). The precipitate
2
was filtered, washed with cold H O (3×5 mL) and dried to give
2
5
4
-amino-1-(2-oxo-2-phenylethyl)-3-(phenylamino)-1H-pyrazole-
-carbonitrile (4a) as a yellow solid Mp. 197 C.
References and notes
o
1
.
Kinnamon, K. E.; Engle, R. R.; Poon, B. T.; Ellis, W. Y.; McCall, J.
-
1
FT-IR (KBr) (νmax, cm ): 3426, 3335, 3242, 3058, 2920,
W.; Pzimianski, M. T. Proc. Soc. Exp. Biol. Med. 2000, 224, 45.
2. Keshi, O.; Bahar, I.; Jernigan, R. L.; Beutler, J. A.; Shoemaker, R.
1
2
205, 1691, 1440, 1559, 1494, 1451, 1225, 745, 686, 561. H
NMR (400 MHz, DMSO-d ) δ (ppm): 8.44 (1H, s, NH,
H.; Sausville, E. A. Covell, D. G. Anti-Cancer Drug. Des. 2000, 15,
6
H
7
9-98.
exchanged by D O addition), 8.04 (2H, d, J = 7.2 Hz, arom), 7.73
2
3
.
Ennis, H. L.; Möller, L.; Wang, J. J.; Selawry, O. S. Biochem.
Pharmacol. 1971, 20, 2639.
(
(
2H, t, J = 7.4 Hz, arom), 7.61 (2H, t, J = 7.8 Hz, arom), 7.48
2H, dd, J = 8.8 Hz, J = 1.2 Hz, arom), 7.72 (2H, t, J = 8 Hz,
1
2
4. Vicentinia, C. B.; Manfrinia, M.; Mazzantia, M.; Scatturina, A.;
Romagnolib, C.; Maresc, D. Arch. Pharm. Pharm Med. Chem. 1999,
332, 337.
arom), 6.79 (2H, br s, NH , exchanged by D O addition), 5.50
2
2
1
3
(
2H, s, CH2). C NMR (100 MHz, DMSO-d ) δ (ppm): 193.26,
6 C
5
.
Dombroski, M. A.; Letavic, M. A.; McClure, K. F. WO 02072576,
002.
1
1
53.42, 150.67, 142.85, 134.97, 134.33, 129.31, 128.89, 128.52,
19.70, 116.73, 115.59, 63.82, 54.46. Anal. Calcd for
2
6
7
.
.
Pelling, J. C.; Shipman, C. J. Biochem. Pharmacol. 1976, 25, 2377.
Matsumoto, M.; Weckbecker, G.; Cory, J. G. Cancer Commun.
C H N O: C, 68.13; H, 4.76; N, 22.07. Found: C, 68.22; H,
1
8
15
5
4
.62; N, 22.21.
1
990, 2, 1.